Immune system cell populations

Immune system cell populations encompass the diverse array of specialized cells that constitute the immune system, including lymphocytes, myeloid cells, and granulocytes [NCI, 2024]. These cells, such as T cells, B cells, natural killer cells, and macrophages, work in a coordinated manner to protect the host from infectious pathogens and eliminate neoplastic cells [StatPearls, 2023]. They originate from hematopoietic stem cells and are distributed throughout the blood, lymph, and lymphoid organs [Janeway's Immunobiology, 2016]. While the term refers to a broad biological category rather than a single molecular entity, these populations are the fundamental units of interest in immunology and pharmacology [Nature Reviews Drug Discovery, 2017]. Therapeutic interventions often target specific proteins expressed by these cells, such as CD20 on B cells or PD-1 on T cells, to modulate immune activity. Dysregulation of these populations can lead to a wide range of pathologies, including autoimmune diseases, immunodeficiencies, and cancer. Consequently, monitoring and manipulating these cell populations is a cornerstone of modern medicine, particularly in the development of vaccines and immunotherapies.

Other names

LeukocytesWhite blood cellsImmune cellsHematopoietic cells

Drugs modulate immune system cell populations by binding to specific surface receptors (e.g., CD20, PD-1), inhibiting intracellular signaling pathways (e.g., calcineurin), or neutralizing cytokines (e.g., TNF-alpha) to either suppress or enhance immune activity [StatPearls, 2023][Janeway's Immunobiology, 2016].